TY - JOUR
T1 - Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes
T2 - A pooled analysis of prospective cohort studies
AU - Fretts, Amanda M.
AU - Imamura, Fumiaki
AU - Marklund, Matti
AU - Micha, Renata
AU - Wu, Jason H.Y.
AU - Murphy, Rachel A.
AU - Chien, Kuo Liong
AU - McKnight, Barbara
AU - Tintle, Nathan
AU - Forouhi, Nita G.
AU - Qureshi, Waqas T.
AU - Virtanen, Jyrki K.
AU - Wong, Kerry
AU - Wood, Alexis C.
AU - Lankinen, Maria
AU - Rajaobelina, Kalina
AU - Harris, Tamara B.
AU - Djoussé, Luc
AU - Harris, Bill
AU - Wareham, Nick J.
AU - Laakso, Markku
AU - Steffen, Lyn M
AU - Samieri, Cécilia
AU - Brouwer, Ingeborg A.
AU - Yu, Chaoyu Ian
AU - Koulman, Albert
AU - Helmer, Catherine
AU - Steffen, Brian
AU - Siscovick, David
AU - Gudnason, Vilmundur
AU - Consortium, Inter Act
AU - Wagenknecht, Lynne
AU - Voutilainen, Sari
AU - Tsai, Michael Y.
AU - Uusitupa, Matti
AU - Tsai, Michael Y
AU - Berr, Claudine
AU - Mozaffarian, Dariush
AU - Lemaitre, Rozenn N.
N1 - Publisher Copyright:
© 2019 American Society for Nutrition. All rights reserved.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Background: Saturated fatty acids (SFAs) of different chain lengths have unique metabolic and biological effects, and a small number of recent studies suggest that higher circulating concentrations of the very-long-chain SFAs (VLSFAs) arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0) are associated with a lower risk of diabetes. Confirmation of these findings in a large and diverse population is needed. Objective: We investigated the associations of circulating VLSFAs 20:0, 22:0, and 24:0 with incident type 2 diabetes in prospective studies. Methods: Twelve studies that are part of the Fatty Acids and Outcomes Research Consortium participated in the analysis. Using Cox or logistic regression within studies and an inverse-varianceweighted meta-analysis across studies, we examined the associations of VLSFAs 20:0, 22:0, and 24:0 with incident diabetes among 51,431 participants. Results: There were 14,276 cases of incident diabetes across participating studies. Higher circulating concentrations of 20:0, 22:0, and 24:0 were each associated with a lower risk of incident diabetes. Pooling across cohorts, the RR (95% CI) for incident diabetes comparing the 90th percentile to the 10th percentile was 0.78 (0.70, 0.87) for 20:0, 0.84 (0.77, 0.91) for 22:0, and 0.75 (0.69, 0.83) for 24:0 after adjustment for demographic, lifestyle, adiposity, and other health factors. Results were fully attenuated in exploratory models that adjusted for circulating 16:0 and triglycerides. Conclusions: Results from this pooled analysis indicate that higher concentrations of circulating VLSFAs 20:0, 22:0, and 24:0 are each associated with a lower risk of diabetes.
AB - Background: Saturated fatty acids (SFAs) of different chain lengths have unique metabolic and biological effects, and a small number of recent studies suggest that higher circulating concentrations of the very-long-chain SFAs (VLSFAs) arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0) are associated with a lower risk of diabetes. Confirmation of these findings in a large and diverse population is needed. Objective: We investigated the associations of circulating VLSFAs 20:0, 22:0, and 24:0 with incident type 2 diabetes in prospective studies. Methods: Twelve studies that are part of the Fatty Acids and Outcomes Research Consortium participated in the analysis. Using Cox or logistic regression within studies and an inverse-varianceweighted meta-analysis across studies, we examined the associations of VLSFAs 20:0, 22:0, and 24:0 with incident diabetes among 51,431 participants. Results: There were 14,276 cases of incident diabetes across participating studies. Higher circulating concentrations of 20:0, 22:0, and 24:0 were each associated with a lower risk of incident diabetes. Pooling across cohorts, the RR (95% CI) for incident diabetes comparing the 90th percentile to the 10th percentile was 0.78 (0.70, 0.87) for 20:0, 0.84 (0.77, 0.91) for 22:0, and 0.75 (0.69, 0.83) for 24:0 after adjustment for demographic, lifestyle, adiposity, and other health factors. Results were fully attenuated in exploratory models that adjusted for circulating 16:0 and triglycerides. Conclusions: Results from this pooled analysis indicate that higher concentrations of circulating VLSFAs 20:0, 22:0, and 24:0 are each associated with a lower risk of diabetes.
KW - Cohorts for Heart and Aging Research in Genomic Epidemiology
KW - Diabetes
KW - Fatty Acids and Outcomes Research Consortium
KW - Meta-analysis
KW - Saturated fatty acids
KW - Very-long-chain saturated fatty acids
UR - http://www.scopus.com/inward/record.url?scp=85064852688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064852688&partnerID=8YFLogxK
U2 - 10.1093/ajcn/nqz005
DO - 10.1093/ajcn/nqz005
M3 - Article
C2 - 30982858
AN - SCOPUS:85064852688
SN - 0002-9165
VL - 109
SP - 1216
EP - 1223
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
IS - 4
ER -